Because these chromatin marks seem to be maintained differentially on essentially identical alleles over many cell generations, it appears that there must be some basic underlying feature that directs ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer ...

Cardiff University researchers discovered how a particularly severe type of DNA damage occurs, giving fresh insight into mutation mechanisms that contribute to cancer and inherited genetic diseases.

Diagnostic bone marrow samples were prepared for cytogenetic analysis using standard techniques involving overnight culture and G-banding. Chromosomal abnormalities were identified and classified ...

Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of ...

This figure depicts how bridge recombinases have a dual targeting capability that enable these systems to insert new genetic material, delete unwanted regions, or flip existing DNA segments all in a ...

For decades, gene-editing science has been limited to making small, precise edits to human DNA, akin to correcting typos in the genetic code. Arc Institute researchers are changing that paradigm with ...

The FDA Friday approved pemigatinib (Pemazyre), a selective fibroblast growth factor (FGFR) inhibitor, to treat adults who have relapsed or refractory (R/R) myeloid/lymphoid neoplasms (MLNs) with ...